The Latest Breaking News from Scott Wiener

A community ignored and undermined during the Aids crisis 40 years ago feels they are again being failed by the government

WASHINGTON — What if Congress enacts a federal ban on abortion?

As criticism grows from LGBTQ activists and others, the Los Angeles County Department of Public Health said it will expand eligibility for the monkeypox vaccine to certain patients with recent sexually transmitted diseases and to high-risk people at Men’s Central Jail.

California Gov. Gavin Newsom on Thursday signed a controversial bill to repeal a provision of state law that bans loitering for the intent to sell sex — a proposal that deeply divided Democrats in the Legislature and pitted transgender rights activists against advocates to stop human trafficking.

Good News In New York: First Meeting Of NY Cannabis Advisory Board and First Legal Marijuana Harvest

Scott Wiener’s Safe Consumption Sites Bill Passes Assembly, Heads Back To Senate The measure to authorize safe consumption sites for illicit drugs, through certain jurisdictions in California as part of a pilot program was approved by the state Assembly on Thursday.

Delaware Bill To Allow Medical Marijuana Patients To Own Guns Heads To Senate Floor

California lawmakers are finally sending Gov. Gavin Newsom a bill that would bar police from making arrests on a charge of loitering for prostitution, nine months after it passed the Legislature

A controversial bill to repeal a provision of California law that prohibits loitering with the intent to sell sex is on its way to Gov. Gavin Newsom's desk, nine months after it passed the Legislature and deeply divided Democrats, sex workers and trafficking survivors along the way.

SACRAMENTO, Calif. — California state Sen. Scott Wiener made a startling revelation at a spring legislative committee hearing: “I was in the hospital. I experienced the most intense abdominal pain that I could even imagine.”

FDA Advisory Panel To Discuss CBD Use In Food & Dietary Supplements The Science Board of the FDA is scheduled to meet on Tuesday, June 14, to discuss “challenges in evaluating the safety of dietary supplement and food ingredients with predicted pharmacological activity, utilizing cannabinoids as a case study.”